Skip to main content

News Archive

News Archive - School of Medicine

Coenzyme Q10 Helps Veterans Battle Gulf War Illness Symptoms

November 3, 2014

In a study published in the Nov. 1 issue of Neural Computation, researchers at the University of California, San Diego School of Medicine report that a high quality brand of coenzyme Q10 (CoQ10) – a compound commonly sold as a dietary supplement – provides health benefits to persons suffering from Gulf War illness symptoms.

Doctors with Early Life Stress Found at Risk for Professional Challenges

October 31, 2014

A study conducted by the UC San Diego Physician Assessment and Clinical Education program (PACE) found that childhood adversity could potentially play a role in a physician’s later professional relationships.

EEG Test to Help Understand and Treat Schizophrenia

October 29, 2014

Researchers at University of California, San Diego School of Medicine have validated an EEG test to study and treat schizophrenia. The findings, published in two separate studies, offer a clinical test that could be used to help diagnose persons at risk for developing mental illness later in life, as well as an approach for measuring the efficacies of different treatment options.

UC San Diego Named Stem Cell “Alpha Clinic”

October 23, 2014

In a push to further speed clinical development of emerging stem cell therapies, Sanford Stem Cell Clinical Center at UC San Diego Health System was named today one of three new “alpha clinics” by the California Institute for Regenerative Medicine, the state’s stem cell agency.

Richard Kronick Elected to Institute of Medicine

October 20, 2014

Richard Kronick, PhD, a health policy expert and faculty member at University of California, San Diego School of Medicine, has been elected to the prestigious Institute of Medicine, the health arm of the National Academy of Sciences and widely regarded as one of the nation’s most respected scientific society.

Promise Put to the Test

October 20, 2014

UC San Diego Sanford Stem Cell Clinical Center is pushing therapeutic stem cell-based science out of the laboratory and closer to real-world medical applications. The unprecedented trials involve potential therapies for spinal cord injuries, Type 1 diabetes and chronic lymphocytic leukemia.

PTPRZ-MET Fusion Protein: A New Target for Personalized Brain Cancer Treatment

October 13, 2014

Researchers at the University of California, San Diego School of Medicine have identified a new fusion protein found in approximately 15 percent of secondary glioblastomas or brain tumors. The finding offers new insights into the cause of this cancer and provides a therapeutic target for personalized oncologic care.

Big Data Sharing for Better Health

October 10, 2014

Researchers at University of California, San Diego School of Medicine have been awarded a $9.2 million grant to help modernize and transform how researchers share, use, find and cite biomedical datasets.

Researchers Unfold New Details About a Powerful Protein

October 9, 2014

Using X-rays and neutron beams, a team of researchers from the University of California, San Diego School of Medicine, University of Utah and Oak Ridge National Laboratory have teased out new information about Protein Kinase A (PKA), a ubiquitous master switch that helps regulate fundamental cellular functions like energy consumption and interactions with hormones, neurotransmitters and drugs.

Two UC San Diego Scientists Honored for Schizophrenia Research

October 7, 2014

Two professors of psychiatry at University of California, San Diego School of Medicine have been honored by the New York City-based Brain & Behavior Research Foundation for their work studying the genetics, dysfunction and treatment of schizophrenia, a chronic and severe brain disorder affecting roughly 1 percent of the general population or approximately 3 million people.
Category navigation with Social links